Studies by leading experts into the power of price momentum show that stocks with the strongest price trends tend to keep up the pace for anywhere up to one year. A big part of the reason for this is down to investor psychology. With...
298380 — ABL Bio Share Price
0.000.00%
Last Trade - 00:00HealthcareHighly SpeculativeMid CapSucker Stock
- KR₩893bn
- KR₩827bn
- KR₩9bn
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | |||
| EPS Growth (f) | |||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | |||
| Price to Tang. Book | |||
| Price to Free Cashflow | |||
| Price to Sales | |||
| EV to EBITDA | |||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | |||
| Return on Equity | |||
| Operating Margin | |||
Financial Summary
| Year End 31st Dec | Unit | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | n/a | 71.43 | 1,257.88 | 3,988.96 | 8,104.2 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health trend(F-Score)
12345678910
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Latest News & Insights for 298380
Profile Summary
ABL Bio Inc. is a company mainly engaged in the development of biopharmaceuticals. The major products include anti-angiogenesis antibodies anti-tumor targeting antibodies, T cell engager bispecific antibodies (TCEs), dual immune cell targeting bispecific antibodies (DICs), novel immune cell targeting antibodies (NICs), brain disease dual antibodies, antibody-drug conjugates (ADCs) , among others.
Directors
- Last Annual
- December 31st, 2020
- Last Interim
- March 31st, 2021
- Incorporated
- February 16th, 2016
- Public Since
- December 19th, 2018
- No. of Shareholders
- 56,418
- No. of Employees
- 91
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 47,123,275
- Address
- SEONGNAM, 13488
- Web
- http://www.ablbio.com/
- Phone
- +82 3180189800
- Auditors
- KPMG Samjong Accounting Corp
Latest News for 298380
Upcoming events for 298380
Q3 2021 ABL Bio Inc Earnings Release
Similar to 298380
AMICOGEN ORD
Korea Exchange - KOSDAQ
APTABIO THERAPE ORD
Korea Exchange - KOSDAQ
BIONEER ORD
Korea Exchange - KOSDAQ
BRIDGE BIO ORD
Korea Exchange - KOSDAQ
CELL BIOTECH ORD
Korea Exchange - KOSDAQ
FAQ
What is the ABL Bio share price?
As of Today at 19:54 UTC, shares in ABL Bio are trading at KR₩18,950. This share price information is delayed by 15 minutes.
How has the ABL Bio share price performed this year?
Shares in ABL Bio last closed at KR₩18,950 and the price had moved by -43.58% over the past 365 days. In terms of relative price strength the ABL Bio share price has underperformed the FTSE Developed Asia Pacific Index by -55.54% over the past year.
What are the analyst and broker recommendations for ABL Bio?
There is no consensus recommendation for this security.
What is the ABL Bio dividend yield?
ABL Bio does not currently pay a dividend.
Does ABL Bio pay a dividend?
ABL Bio does not currently pay a dividend.
When does ABL Bio next pay dividends?
ABL Bio does not currently pay a dividend.
How do I buy ABL Bio shares?
To buy shares in ABL Bio you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of ABL Bio?
As of the previous close price of KR₩18,950, shares in ABL Bio had a market capitalisation of KR₩893bn.
Where are ABL Bio shares listed?
Here are the trading details for ABL Bio:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 298380
What kind of share is ABL Bio?
Based on an overall assessment of its quality, value and momentum ABL Bio is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a ABL Bio share price forecast for 2021?
We could not find analyst target price data for this security.
What is the trend in the ABL Bio share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like ABL Bio. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -9.64%.
As of the last closing price of KR₩18,950, shares in ABL Bio were trading -19.13% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the ABL Bio PE Ratio?
We are not able to find PE ratio data for ABL Bio.
Who are the key directors of ABL Bio?
We do not have data on ABL Bio's directors
Who are the major shareholders of ABL Bio?
We do not have data on ABL Bio's shareholders